Cargando…

Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease

BACKGROUND: There are few effective medications for non-alcoholic steatohepatitis (NASH). We investigated the efficacy of ipragliflozin (selective sodium-glucose cotransporter-2 inhibitor [SGLT2I]) for the treatment of patients with type 2 diabetes mellitus (T2DM) complicated by non-alcoholic fatty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyake, Teruki, Yoshida, Sakiko, Furukawa, Shinya, Sakai, Takenori, Tada, Fujimasa, Senba, Hidenori, Yamamoto, Shin, Koizumi, Yohei, Yoshida, Osamu, Hirooka, Masashi, Kumagi, Teru, Niiya, Tetsuju, Miyaoka, Hiroaki, Masanori, Abe, Matsuura, Bunzo, Hiasa, Yoichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2018
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141887/ https://www.ncbi.nlm.nih.gov/pubmed/30234161 http://dx.doi.org/10.1515/med-2018-0059

Ejemplares similares

Low Urine pH Is Associated with Non-alcoholic Fatty Liver Disease: A Community-based Cross-sectional Study
por: Miyake, Teruki, et al.
Publicado: (2018)

Relationship between urine pH and abnormal glucose tolerance in a community‐based study
por: Yoshida, Sakiko, et al.
Publicado: (2017)

Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study
por: Okamoto, Masashi, et al.
Publicado: (2018)

The Serum Creatinine Level Might Be Associated with the Onset of Impaired Fasting Glucose: A Community-based Longitudinal Cohort Health Checkup Study
por: Yoshida, Naohiko, et al.
Publicado: (2018)

Insulin‐like growth factor‐1 is inversely associated with liver fibrotic markers in patients with type 2 diabetes mellitus
por: Miyauchi, Shozo, et al.
Publicado: (2019)

Fatty liver with metabolic disorder, such as metabolic dysfunction‐associated fatty liver disease, indicates high risk for developing diabetes mellitus
por: Miyake, Teruki, et al.
Publicado: (2022)

Hyperuricemia Is a Risk Factor for the Onset of Impaired Fasting Glucose in Men with a High Plasma Glucose Level: A Community-Based Study
por: Miyake, Teruki, et al.
Publicado: (2014)

Dietary intake habits and the prevalence of nocturia in Japanese patients with type 2 diabetes mellitus
por: Furukawa, Shinya, et al.
Publicado: (2017)

Relationship between body composition and the histology of non‐alcoholic fatty liver disease: a cross‐sectional study
por: Miyake, Teruki, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status
por: Miyake, Teruki, et al.
Publicado: (2021)

Combined evaluation of Fibrosis‐4 index and fatty liver for stratifying the risk for diabetes mellitus
por: Todo, Yasuhiko, et al.
Publicado: (2022)

Observational Study on Unhealthy Eating Behavior and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors: The Luseogliflozin Ehime Diabetes Study
por: Furukawa, Shinya, et al.
Publicado: (2022)

Nocturia and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: The Dogo Study
por: Furukawa, Shinya, et al.
Publicado: (2016)

Physical activity and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: The Dogo Study
por: Minami, Hisaka, et al.
Publicado: (2017)

Macrovascular Complications and Prevalence of Urgency Incontinence in Japanese Patients with Type 2 Diabetes Mellitus: The Dogo Study
por: Furukawa, Shinya, et al.
Publicado: (2017)

Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease
por: Nakamura, Yoshiko, et al.
Publicado: (2019)

Treatment on the Spleen Prevents the Progression of Secondary Sarcopenia in Patients With Liver Cirrhosis
por: Hirooka, Masashi, et al.
Publicado: (2020)

B cell activating factor in obesity is regulated by oxidative stress in adipocytes
por: Tada, Fujimasa, et al.
Publicado: (2013)

Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis
por: Miyake, Teruki, et al.
Publicado: (2022)

Additional Effect of Luseogliflozin on Semaglutide in Nonalcoholic Steatohepatitis Complicated by Type 2 Diabetes Mellitus: An Open-Label, Randomized, Parallel-Group Study
por: Miyake, Teruki, et al.
Publicado: (2022)

Increased B Cell-Activating Factor Promotes Tumor Invasion and Metastasis in Human Pancreatic Cancer
por: Koizumi, Mitsuhito, et al.
Publicado: (2013)

Role of B Cell-Activating Factor in Fibrosis Progression in a Murine Model of Non-Alcoholic Steatohepatitis
por: Kanemitsu-Okada, Kozue, et al.
Publicado: (2023)

Nonalcoholic fatty liver with a hepatic arterial buffer response strongly associated with future metabolic disease
por: Hirooka, Masashi, et al.
Publicado: (2017)

Endoscopic stent placement above the sphincter of Oddi for biliary strictures after living donor liver transplantation
por: Koizumi, Mitsuhito, et al.
Publicado: (2020)

Quantitative imaging of fibrotic and morphological changes in liver of non-alcoholic steatohepatitis (NASH) model mice by second harmonic generation (SHG) and auto-fluorescence (AF) imaging using two-photon excitation microscopy (TPEM)
por: Yamamoto, Shin, et al.
Publicado: (2016)

Effects of Motilin Receptor Agonists and Ghrelin in Human motilin receptor Transgenic Mice
por: Kawamura, Tomoe, et al.
Publicado: (2019)

Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate
por: Kumagi, Teru, et al.
Publicado: (2023)

Ileal mucosa-associated microbiota overgrowth associated with pathogenesis of primary biliary cholangitis
por: Kitahata, Shogo, et al.
Publicado: (2021)

Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collaborative retrospective multicenter clinical review of 1,082 patients
por: Kuroda, Taira, et al.
Publicado: (2013)

Usefulness of a New Three-Dimensional Simulator System for Radiofrequency Ablation
por: Hirooka, Masashi, et al.
Publicado: (2016)

Infection as a Risk Factor in the Pathogenesis of Primary Biliary Cirrhosis: Pros and Cons
por: Kumagi, Teru, et al.
Publicado: (2010)

Destructive Thyroiditis Induced by Lenvatinib in Three Patients with Hepatocellular Carcinoma
por: Hirooka, Masashi, et al.
Publicado: (2018)

Utility of Contrast-Enhanced Transabdominal Ultrasonography to Diagnose Early Chronic Pancreatitis
por: Azemoto, Nobuaki, et al.
Publicado: (2015)

Characterization of Liver Monocytic Myeloid-Derived Suppressor Cells and Their Role in a Murine Model of Non-Alcoholic Fatty Liver Disease
por: Yao, Liying, et al.
Publicado: (2016)

Survival Improvements in Advanced Hepatocellular Carcinoma with Sequential Therapy by Era
por: Nakamura, Yoshiko, et al.
Publicado: (2023)

Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma
por: Ohno, Yoshinori, et al.
Publicado: (2017)

Apoptosis-associated speck-like protein containing a CARD regulates the growth of pancreatic ductal adenocarcinoma
por: Koizumi, Mitsuhito, et al.
Publicado: (2021)

Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer
por: Terao, Takashi, et al.
Publicado: (2021)

Muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluation
por: Hiraoka, Atsushi, et al.
Publicado: (2015)

Education and household income and carotid intima-media thickness in Japan: baseline data from the Aidai Cohort Study in Yawatahama, Uchiko, Seiyo, and Ainan
por: Miyake, Yoshihiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m55k6m71ot42kt08l53hapjdcu